Brief description of ibrutinib/ibrutinib medication guidelines

Ibrutinib/Ibrutinib, as a potent inhibitor of Bruton's tyrosine kinase (BTK), has achieved remarkable results in the treatment of various B cell malignancies such as chronic lymphocytic leukemia (CLL) in recent years. This article will briefly describe the guidelines for using this drug.

1. Necessary preparations before taking medicine

Before starting ibrutinib treatment, patients need to undergo a comprehensive physical examination, covering blood routine, liver function, kidney function and other aspects to ensure that the physical condition meets the medication standards. At the same time, patients should inform their doctors in detail about their allergies, medication history, and other diseases so that doctors can make more accurate medication decisions.

2. Correct medication method

Ibrutinib is usually taken as an oral tablet, and patients should take it strictly according to their doctor's instructions. It is recommended to drink it with a full glass of water and maintain a stable medication time. Do not change the dosage or stop medication at will. Special reminder, please swallow the medicine whole and do not crush, chew, break or open the capsule.

3. Precautions during medication

1. Side effect monitoring: During the use of ibrutinib, patients may experience side effects such as bleeding, infection, and heart problems. Therefore, it is necessary to go to the hospital regularly for blood routine monitoring, infection indicators and other monitoring in order to detect and deal with possible side effects in a timely manner.

2. Prevention of infection: Because ibrutinib may affect immune system function, patients should avoid contact with sources of infection, such as cold or flu patients, during treatment.

3. Diet adjustment: Patients are advised to maintain a balanced diet and avoid greasy or irritating foods during treatment to reduce gastrointestinal discomfort. Also, grapefruit and Seville orange may interact with ibrutinib and cause side effects, so grapefruit products and orange marmalade should be avoided.

4. Drug interactions: Ibrutinib may interact with certain drugs, so patients should inform their doctors about all the drugs they are taking before taking the drug.

4. Follow-up consultation and effect evaluation

During the treatment period, patients should follow the doctor's recommendations for regular follow-up visits so that the doctor can evaluate the treatment effects and side effects. At the same time, patients should also promptly report any discomfort symptoms or concerns to the doctor so that they can receive timely answers and treatment.

In short, ibrutinib/Ibrutinib is used to treat chronic lymphocytic leukemia, etc.BEffective drugs for cellular malignancies. During use, patients need to strictly follow the doctor's instructions, pay attention to the medication methods and precautions, and make regular follow-up visits to evaluate the treatment effect. Currently, there are many versions of this drug available at different prices. Patients are asked to make their own choice, but be sure to purchase through regular channels and be careful to identify the authenticity of the drug.